Comparative evaluation of early diabetic outcomes in southeast asian patients with type 2 diabetes mellitus undergoing Roux-en-Y gastric bypass (RYGB) versus sleeve gastrectomy (LSG)

Wei Soon Pang,Guo Hou Loo,Guo Jeng Tan,Mardiana Mardan,Reynu Rajan,Nik Ritza Kosai
DOI: https://doi.org/10.1038/s41598-024-51384-1
IF: 4.6
2024-01-06
Scientific Reports
Abstract:Obesity and type 2 diabetes mellitus (T2DM) is an alarming problem globally and a growing epidemic. Metabolic surgery has been shown to be successful in treating both obesity and T2DM, usually after other treatments have failed. This study aims to compare Roux-Y gastric bypass and sleeve gastrectomy in determining early diabetic outcomes in obese Malaysian patients with T2DM following surgery. A total of 172 obese patients with T2DM who were assigned to either laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (LSG) were analysed up to a year post-procedure. The patients' T2DM severity were stratified using the Individualized Metabolic Surgery (IMS) score into mild, moderate and severe. Remission rates of diabetes were compared between surgical techniques and within diabetic severity categories. T2DM remission for patients who underwent either surgical technique for mild, moderate or severe disease was 92.9%, 56.2% and 14.7% respectively. Both surgical techniques improved T2DM control for patients in the study. Comparing baseline with results 1 year postoperatively, median HbA1c reduced from 7.40% (IQR 2.60) to 5.80% (IQR 0.80) ( p < 0.001), mean total antidiabetic medications use reduced from 1.48 (SD 0.99) to 0.60 (SD 0.86) [ p < 0.001], insulin usage reduced from 27.9 to 10.5% ( p < 0.001), and T2DM control improved from 27.9 to 82% ( p < 0.001). The patients had a median excess BMI loss of 69.4% (IQR 34%) and 53.2% (IQR 36.0%) for RYGB and SG respectively ( p = 0.016). At one year following surgery, there is no difference between LRYGB and LSG in terms of diabetic remission. LSG is not inferior to LRYGB in terms of early diabetic outcomes. Milder T2DM shows a better response. LSG is a simpler procedure with a lower risk profile and should be considered as an early treatment option for obese patients with T2DM.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: **Compare the early diabetes treatment effects of Roux - en - Y gastric bypass (LRYGB) and sleeve gastrectomy (LSG) in obese type 2 diabetes mellitus (T2DM) patients in Southeast Asia, in order to determine which surgical method is more suitable for improving diabetes outcomes**. ### Core problem decomposition of the paper: 1. **Differences in surgical selection**: Is there a certain surgical method (LRYGB or LSG) that is superior in terms of diabetes remission rate, blood - glucose control, and reduction in drug use? 2. **Influence of diabetes severity**: Does different diabetes severity (classified as mild, moderate, and severe by the Individualized Metabolic Surgery, IMS score) have a significant impact on the effects of the two surgical methods? 3. **Relationship between weight loss and diabetes remission**: Is the degree of weight loss after surgery directly related to the diabetes remission rate? 4. **Potential for long - term efficacy**: Although the study only focuses on the results one year after surgery, can it provide a preliminary reference for future long - term follow - up? --- ### Main findings of the paper: 1. **Overall diabetes remission rate**: - The remission rate for mild T2DM patients is 92.9%, 56.2% for moderate ones, and only 14.7% for severe ones. This indicates that the milder the diabetes, the better the remission effect after surgery. - There is no significant difference in the diabetes remission rate between LSG and LRYGB (59% and 54.2% respectively). 2. **Differences in weight loss**: - LRYGB performs better in terms of weight loss, with an excess body mass index loss (EBMIL) of 69.4%, while LSG is 53.2% (p = 0.016). - However, the degree of weight loss does not directly affect the diabetes remission rate. 3. **Surgical safety and complexity**: - LSG is a simpler and lower - risk surgical method, especially suitable for mild and moderate T2DM patients. - Although LRYGB is more effective in terms of weight loss, it may be accompanied by a higher risk of nutritional deficiencies (such as iron and vitamin B12 deficiencies). 4. **Application of IMS score**: - The IMS score has certain value in predicting the diabetes remission rate, but has limited effect in guiding the selection of specific surgical methods. --- ### Conclusion: The main objective of this study is to provide scientific basis for clinicians to help select the appropriate metabolic surgery method for obese T2DM patients. The study shows that **for the early diabetes treatment effect, LSG is not inferior to LRYGB**, but due to the advantage of LRYGB in weight loss, the most appropriate surgical method still needs to be selected according to the specific situation of the patient.